Wealthcare Advisory Partners’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
31,766
-575
-2% -$26.6K 0.03% 421
2026
Q1
$1.59M Sell
32,341
-797
-2% -$37.1K 0.03% 404
2025
Q4
$1.44M Buy
33,138
+7,140
+27% +$326K 0.03% 424
2025
Q3
$1.17M Buy
25,998
+452
+2% +$19.9K 0.02% 458
2025
Q2
$1.11M Buy
25,546
+362
+1% +$16.1K 0.03% 455
2025
Q1
$1.16M Buy
25,184
+1,948
+8% +$81.4K 0.03% 415
2024
Q4
$875K Buy
23,236
+525
+2% +$20.4K 0.02% 452
2024
Q3
$921K Sell
22,711
-117
-0.5% -$4.4K 0.03% 439
2024
Q2
$790K Buy
22,828
+3,655
+19% +$135K 0.02% 446
2024
Q1
$720K Buy
19,173
+80
+0.4% +$2.86K 0.02% 467
2023
Q4
$685K Buy
19,093
+28
+0.1% +$1.08K 0.03% 411
2023
Q3
$720K Sell
19,065
-1,781
-9% -$72.6K 0.03% 346
2023
Q2
$849K Buy
20,846
+893
+4% +$36.9K 0.04% 321
2023
Q1
$836K Buy
19,953
+13
+0.1% +$542 0.04% 325
2022
Q4
$862K Buy
19,940
+1,330
+7% +$52.5K 0.04% 303
2022
Q3
$697K Buy
18,610
+310
+2% +$13.7K 0.04% 287
2022
Q2
$829K Buy
18,300
+1,492
+9% +$70.1K 0.05% 233
2022
Q1
$801K Sell
16,808
-6,353
-27% -$269K 0.05% 226
2021
Q4
$954K Buy
23,161
+5,012
+28% +$189K 0.06% 204
2021
Q3
$626K Sell
18,149
-346
-2% -$11.8K 0.04% 277
2021
Q2
$585K Sell
18,495
-410
-2% -$13.2K 0.04% 286
2021
Q1
$590K Buy
18,905
+93
+0.5% +$2.79K 0.04% 260
2020
Q4
$566K Buy
18,812
+109
+0.6% +$3.22K 0.05% 217
2020
Q3
$477K Buy
18,703
+55
+0.3% +$1.46K 0.05% 205
2020
Q2
$483K Buy
18,648
+1,982
+12% +$52.6K 0.06% 178
2020
Q1
$438K Buy
16,666
+2,569
+18% +$80.8K 0.06% 168
2019
Q4
$458K Sell
14,097
-1,136
-7% -$36.8K 0.06% 181
2019
Q3
$525K Buy
15,233
+2,961
+24% +$99.4K 0.08% 145
2019
Q2
$420K Sell
12,272
-1,333
-10% -$47K 0.07% 158
2019
Q1
$486K Sell
13,605
-73
-0.5% -$2.49K 0.08% 138
2018
Q4
$440K Buy
13,678
+23
+0.2% +$736 0.09% 127
2018
Q3
$425K Sell
13,655
-2,594
-16% -$79.8K 0.08% 137
2018
Q2
$494K Buy
16,249
+71
+0.4% +$2.03K 0.1% 121
2018
Q1
$450K Buy
16,178
+27
+0.2% +$729 0.1% 113
2017
Q4
$454K Buy
16,151
+744
+5% +$21.4K 0.12% 103
2017
Q3
$414K Buy
+15,407
New +$412K 0.12% 92

Other funds holding EXC

Wealthcare Advisory Partners's EXC Position: Q2 2026 in Review

Wealthcare Advisory Partners reduced its Exelon (EXC) stake by 1.8% in Q2 2026, selling an estimated $26.6K and leaving 31,766 shares worth $1.48M. The position accounts for 0.03% of the portfolio, ranked #421.

Wealthcare Advisory Partners first reported a position in EXC in Q3 2017 and has held it in 36 quarters since. The position peaked at $1.59M in Q1 2026. 282 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Wealthcare Advisory Partners held 31,766 shares of Exelon worth $1.48M as of Q2 2026.
  • Wealthcare Advisory Partners sold 575 Exelon shares in Q2 2026, an estimated $26.6K.
  • Exelon made up 0.03% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #421 holding.
  • Wealthcare Advisory Partners first reported a position in Exelon in Q3 2017 and has held it in 36 quarters since.
  • Wealthcare Advisory Partners's Exelon position peaked at $1.59M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.